In8Bio (INAB) Accounts Payables (2020 - 2026)
In8Bio's Accounts Payables was $444,000 in Q2 2026, up 17.2% from $379,000 a year earlier but down 1.1% from the prior quarter.
Powered by 
Analysis
In8Bio (INAB) Accounts Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, Accounts Payables at In8Bio came in at $309,000, down 20.6% from FY2024.
- Accounts Payables has now declined for three consecutive years, with a five-year compound annual growth rate of -13.0% (FY2020 to FY2025).
- In earlier years, Accounts Payables was $389,000 in FY2024 (-57.9%), $924,000 in FY2023 (-55.8%), $2.09 million in FY2022 (+429.4%) and $395,000 in FY2021 (-36.3%).
- Quarterly Accounts Payables has moved between $204,000 (Q3 2025) and $2.09 million (Q4 2022) over five years.
- Compared with a year earlier, Accounts Payables was higher in two of the last seven quarters, with an average decline of 26.7%.
- The best year-over-year quarter for Accounts Payables over five years was Q4 2022 (growth of 429.4%); the worst was Q3 2025 (a decline of 82.1%).
- Per Business Quant data, INAB's Accounts Payables in the three quarters before Q2 2026 was $449,000 (Q1 2026), $309,000 (Q4 2025) and $204,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 9.32 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 4.58 Bn |
| 10 | In8Bio | 20.44 Mn | -57.91 Mn | - | 444,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 444,000.00 |
| Mar 31, 2026 | 449,000.00 |
| Dec 31, 2025 | 309,000.00 |
| Sep 30, 2025 | 204,000.00 |
| Jun 30, 2025 | 379,000.00 |
| Mar 31, 2025 | 575,000.00 |
| Dec 31, 2024 | 389,000.00 |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Dec 31, 2023 | 924,000.00 |
| Sep 30, 2023 | 748,000.00 |
| Jun 30, 2023 | 585,000.00 |
| Mar 31, 2023 | 870,000.00 |
| Dec 31, 2022 | 2.09 Mn |
| Sep 30, 2022 | 1.11 Mn |
| Jun 30, 2022 | 887,000.00 |
| Mar 31, 2022 | 553,000.00 |
| Dec 31, 2021 | 395,000.00 |
| Sep 30, 2021 | 692,000.00 |
| Jun 30, 2021 | 462,000.00 |
API Access
In8Bio Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=INAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "INAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=INAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();